-
Product Insights
NewLikelihood of Approval Analysis for Chemotherapy Effects
Overview How likely is it that the drugs in Chemotherapy Effects will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chemotherapy Effects Overview Chemotherapy effects are the unwanted effects that can be...
-
Product Insights
NewLikelihood of Approval Analysis for Chemotherapy Induced Nausea and Vomiting
Overview How likely is it that the drugs in Chemotherapy Induced Nausea and Vomiting will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chemotherapy Induced Nausea and Vomiting Overview Chemotherapy-induced nausea and...
-
Product Insights
NewLikelihood of Approval Analysis for Ocular Melanoma
Overview How likely is it that the drugs in Ocular Melanoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ocular Melanoma Overview Ocular melanoma is an extremely rare form of cancer...
-
Product Insights
NewLikelihood of Approval Analysis for Polycythemia Vera
Overview How likely is it that the drugs in Polycythemia Vera will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polycythemia Vera Overview Polycythemia vera (PV) is a stem cell disorder characterized...
-
Product Insights
NewLikelihood of Approval Analysis for Posterior Uveitis
Overview How likely is it that the drugs in Posterior Uveitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Posterior Uveitis Overview Posterior uveitis refers to intraocular inflammation in the vitreous,...
-
Product Insights
NewLikelihood of Approval Analysis for Retinitis Pigmentosa (Retinitis)
Overview How likely is it that the drugs in Retinitis Pigmentosa (Retinitis) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Retinitis Pigmentosa (Retinitis) Overview Retinitis pigmentosa refers to a group of...
-
Product Insights
NewLikelihood of Approval Analysis for Rhino-Conjunctivitis
Overview How likely is it that the drugs in Rhino-Conjunctivitis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rhino-Conjunctivitis Overview Rhinitis is characterized by one or several of the following symptoms:...
-
Product Insights
NewLikelihood of Approval Analysis for Systemic Sclerosis (Scleroderma)
Overview How likely is it that the drugs in Systemic Sclerosis (Scleroderma) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systemic Sclerosis (Scleroderma) Overview Scleroderma is a group of rare diseases...
-
Product Insights
NewLikelihood of Approval Analysis for Bacterial Vaginosis
Overview How likely is it that the drugs in Bacterial Vaginosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bacterial Vaginosis Overview Bacterial vaginosis (BV), also known as vaginal bacteriosis, is...
-
Product Insights
NewLikelihood of Approval Analysis for Pertussis (Whooping Cough)
Overview How likely is it that the drugs in Pertussis (Whooping Cough) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pertussis (Whooping Cough) Overview Pertussis, also known as whooping cough, is...